TRIM33 and colorectal cancer: Shi et al. [49] reported that loss of TRIM33 or TRIM24 can lead to resistance to potent BET inhibitors (BETi) JQ1 and GS-626510 in colorectal cancer, suggesting both TRIM24 and TRIM33 can be directly targeted by BETi.